Travasol NDC 0338-0644

NDC codes

FDA NDC Directory

Product NDC (as listed)0338-0644Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00338-0644Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0338-0644-03	00338064403	500 mL in 1 BAG (0338-0644-03)Marketed from Aug 23, 1984
0338-0644-04	00338064404	1000 mL in 1 BAG (0338-0644-04)Marketed from Aug 23, 1984
0338-0644-06	00338064406	2000 mL in 1 BAG (0338-0644-06)Marketed from Aug 23, 1984

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Travasol
Generic name (nonproprietary): leucine, phenylalanine, lysine hydrochloride, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, tyrosine, serine
Active ingredients: Leucine — 730 mg/100mLPhenylalanine — 560 mg/100mLLysine hydrochloride — 580 mg/100mLMethionine — 400 mg/100mLIsoleucine — 600 mg/100mLValine — 580 mg/100mLHistidine — 480 mg/100mLThreonine — 420 mg/100mLTryptophan — 180 mg/100mLAlanine — 2.07 g/100mLGlycine — 1.03 g/100mLArginine — 1.15 g/100mLProline — 680 mg/100mLTyrosine — 40 mg/100mLSerine — 500 mg/100mL
Dosage form: Injection
Route: Intravenous
Labeler: Baxter Healthcare Corporation
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018931
Marketing start: Aug 23, 1984
Listing expires: Dec 31, 2026
Other FDA classes: Amino Acids (Chemical structure)
Identifiers: Product ID 0338-0644_e0279078-016d-48fd-8de1-c894422b33ffSPL ID e0279078-016d-48fd-8de1-c894422b33ffSPL set ID 8543b5be-0f43-4891-9e56-d7c39fe839b5RxCUI 801644, 801648UNII GMW67QNF9C, 47E5O17Y3R, JNJ23Q2COM, AE28F7PNPL, 04Y7590D77, HG18B9YRS7, 4QD397987E, 2ZD004190S, 8DUH1N11BX, OF5P57N2ZX, TE7660XO1C, 94ZLA3W45F, 9DLQ4CIU6V, 42HK56048U, 452VLY9402
Pharmacologic class: Amino Acid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400338064403 followed by a unit qualifier and the quantity

Package 00338-0644-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 7, 2020.

Indications (excerpt from the label)

TRAVASOL is indicated as a source of amino acids for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. TRAVASOL may be used to treat negative nitrogen balance in patients. TRAVASOL is indicated as a source of amino acids for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. TRAVASOL may be used to treat negative nitrogen balance in patients. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)